Federico de la Rosa
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori(IT)
Publications by Year
Research Areas
Epigenetics and DNA Methylation, Bladder and Urothelial Cancer Treatments, Renal Transplantation Outcomes and Treatments, Cancer-related molecular mechanisms research, Organ Transplantation Techniques and Outcomes
Most-Cited Works
- → Results of a phase III trial of erlotinib (OSI-774) combined with cisplatin and gemcitabine (GC) chemotherapy in advanced non-small cell lung cancer (NSCLC)(2004)300 cited
- → BMP4 Induces M2 Macrophage Polarization and Favors Tumor Progression in Bladder Cancer(2017)217 cited
- → Randomized phase III trial comparing adjuvant paclitaxel/gemcitabine/cisplatin (PGC) to observation in patients with resected invasive bladder cancer: Results of the Spanish Oncology Genitourinary Group (SOGUG) 99/01 study.(2010)164 cited
- → UroMark—a urinary biomarker assay for the detection of bladder cancer(2017)129 cited
- → In Vivo Disruption of an Rb–E2F–Ezh2 Signaling Loop Causes Bladder Cancer(2014)89 cited
- → PIK3CA gene alterations in bladder cancer are frequent and associate with reduced recurrence in non-muscle invasive tumors(2013)65 cited
- → Analysis of the Polycomb-related lncRNAs HOTAIR and ANRIL in bladder cancer(2015)62 cited
- → Kidney transplant from uncontrolled donation after circulatory death donors maintained by nECMO has long-term outcomes comparable to standard criteria donation after brain death(2018)60 cited
- → CDK4/6 Inhibitor as a Novel Therapeutic Approach for Advanced Bladder Cancer Independently of RB1 Status(2018)57 cited
- → Multiparametric Implantable Cardioverter-Defibrillator Algorithm for Heart Failure Risk Stratification and Management: An Analysis in Clinical Practice(2021)46 cited